IGHE and anaphylaxis: Indeed, Siglec-8 mAbs have been shown to inhibit both IgE-dependent and -independent MC activation in vivo, including systemic anaphylaxis in humanized mice and IL-33- and Substance P-mediated MC activation in Siglec-8 transgenic mice (12–14).